Skip to content

THE EFFECT OF SURGICAL MASK AND N95 MASK USE ON SURGICAL SMOKE IN OPERATING ROOM NURSES

COMPARISON OF THE EFFECTS OF SURGICAL MASK AND N95 MASK USE ON PHYSICAL SYMPTOMS OF SURGICAL SMOKE IN OPERATING ROOM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07404956
Enrollment
38
Registered
2026-02-12
Start date
2024-09-15
Completion date
2026-02-28
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain (AP), Dispnea, Dizziness, Eye Allergies, Fatigue Symptom, Headache, Heart Rate Determination, Muscle Aches, Muscle Weakness | Patient, Nause and Vomiting, Occupational Exposure to Surgical Smoke, SpO2, Surgical Smoke Exposure

Keywords

Surgical Smoke, Masks, Operating Room Nurses, Occupational Exposure

Brief summary

This study was conducted to compare the effect of surgical mask and N95 mask use on physical symptoms due to surgical smoke in operating theatre nurses. The study, which was conducted in a single-group prospective quasi-experimental design, was completed with 38 nurses in the operating theatre unit of a state hospital in the Western Black Sea Region. Data were collected for four weeks using the Descriptive Information Form, Numerical Rating Scale and Symptom Follow-up Form. According to the findings, muscle weakness, myalgia in the upper extremities and muscle cramps were statistically significantly less in nurses using N95 masks. Respiratory parameters, watery eyes and redness were significantly lower in nurses using surgical masks. As a result, it was determined that the type of mask was effective on the incidence of physical symptoms related to surgical smoke.

Interventions

Standard surgical masks were used by operating room nurses during surgical procedures with exposure to surgical smoke.

DEVICEN95 Mask

N95 respirators were used by operating room nurses during surgical procedures with exposure to surgical smoke.

Sponsors

Bartın Unıversity
Lead SponsorOTHER
Bartin State Hospital
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Masking description

Outcome assessment and data analysis were conducted by an independent assessor blinded to the type of mask used.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Willingness to participate in the study * Aged 18 years or older * Working as a sterile operating room nurse at least 4 hours per day, 5 days per week * Compliance with the protocol requiring continuous use of both surgical mask and N95 mask for at least 4 hours per day * Ability to communicate verbally and provide informed consent

Exclusion criteria

* Diagnosed psychiatric disorders * Presence of chronic respiratory, musculoskeletal, or neurological diseases * Presence of chronic dermatological conditions or allergies affecting the facial or respiratory area * Speech or communication impairments * Pregnancy * Holding a supervisory role (e.g., charge nurse) or non-sterile nursing role * Planned unit change or rotation during the study period

Design outcomes

Primary

MeasureTime frameDescription
Surgical Smoke-Related Physical Symptom Severity (Total NRS Score)Five days per week for a duration of four weeks both preoperatively and postoperativelyThe severity of physical symptoms related to surgical smoke exposure in operating room nurses, including headache, abdominal pain, nausea and vomiting, fatigue/weakness, loss of appetite, and dyspnea, was assessed using the Numeric Rating Scale (NRS). Each symptom was rated on a standardized numeric scale, and a total symptom severity score was calculated by summing the individual symptom scores. Higher scores indicate greater symptom severity.

Countries

Turkey (Türkiye)

Contacts

CONTACTHilal Çetin Baltutar, Nurse
hilalcetinbaltutar@gmail.com+905336087874
CONTACTSevim Çelik, Proffessor
scelik@bartin.edu.tr+905327832989
PRINCIPAL_INVESTIGATORsevim çelik, Professor

Bartin University Health Science Faculty

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026